New PET Biomarker for Giant Cell Arteritis
Researchers have developed a new PET tracer that targets vascular inflammation, offering a potential biomarker for diagnosing and monitoring giant cell arteritis. The study shows the tracer correlates with disease activity and responds to steroid treatment.
Why it matters
This advancement could significantly improve the accuracy of diagnosing and managing a condition that is currently difficult to track with existing clinical tools.
A NOVEL PET tracer that lights up inflamed blood vessels could become a much-needed biomarker for giant cell arteritis, a first-in-human study suggests, after it tracked vascular disease activity and faded as steroid treatment took hold.
The article is a technical summary of a medical research study.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in